Kolte-Patil Developers Croissance future
Future contrôle des critères 6/6
Kolte-Patil Developers devrait augmenter ses bénéfices et son chiffre d'affaires de 74.7% et de 26.3% par an respectivement. Le BPA devrait croître de de 73.8% par an. Le rendement des capitaux propres devrait être 21.1% dans 3 ans.
Informations clés
74.7%
Taux de croissance des bénéfices
73.8%
Taux de croissance du BPA
Real Estate croissance des bénéfices | 27.1% |
Taux de croissance des recettes | 26.3% |
Rendement futur des capitaux propres | 21.1% |
Couverture par les analystes | Low |
Dernière mise à jour | 14 Nov 2024 |
Mises à jour récentes de la croissance future
Kolte-Patil Developers Limited Just Missed EPS By 57%: Here's What Analysts Think Will Happen Next
Nov 16Kolte-Patil Developers Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
May 29Recent updates
Kolte-Patil Developers Limited Just Missed EPS By 57%: Here's What Analysts Think Will Happen Next
Nov 16Kolte-Patil Developers (NSE:KOLTEPATIL) Is Due To Pay A Dividend Of ₹4.00
Jul 28New Forecasts: Here's What Analysts Think The Future Holds For Kolte-Patil Developers Limited (NSE:KOLTEPATIL)
May 30Kolte-Patil Developers Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
May 29Optimistic Investors Push Kolte-Patil Developers Limited (NSE:KOLTEPATIL) Shares Up 34% But Growth Is Lacking
Apr 13We Ran A Stock Scan For Earnings Growth And Kolte-Patil Developers (NSE:KOLTEPATIL) Passed With Ease
Apr 11Earnings Tell The Story For Kolte-Patil Developers Limited (NSE:KOLTEPATIL)
Jan 05Is Kolte-Patil Developers (NSE:KOLTEPATIL) Using Too Much Debt?
Nov 21Here's Why Kolte-Patil Developers (NSE:KOLTEPATIL) Has Caught The Eye Of Investors
Nov 02These 4 Measures Indicate That Kolte-Patil Developers (NSE:KOLTEPATIL) Is Using Debt Reasonably Well
Jun 01These 4 Measures Indicate That Kolte-Patil Developers (NSE:KOLTEPATIL) Is Using Debt Extensively
Jun 01How Should Investors Feel About Kolte-Patil Developers' (NSE:KOLTEPATIL) CEO Remuneration?
Feb 28What Percentage Of Kolte-Patil Developers Limited (NSE:KOLTEPATIL) Shares Do Insiders Own?
Feb 07Have Insiders Been Buying Kolte-Patil Developers Limited (NSE:KOLTEPATIL) Shares?
Jan 17The Kolte-Patil Developers (NSE:KOLTEPATIL) Share Price Is Up 55% And Shareholders Are Holding On
Dec 27Does Kolte-Patil Developers (NSE:KOLTEPATIL) Have A Healthy Balance Sheet?
Nov 30Here's What We Think About Kolte-Patil Developers' (NSE:KOLTEPATIL) CEO Pay
Nov 04Trade Alert: The Independent Non-Executive Director Of Kolte-Patil Developers Limited (NSE:KOLTEPATIL), Umesh Joshi, Has Just Spent ₹1.6m Buying A Few More Shares
Sep 30What Type Of Returns Would Kolte-Patil Developers'(NSE:KOLTEPATIL) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Sep 17Are Kolte-Patil Developers's (NSE:KOLTEPATIL) Statutory Earnings A Good Guide To Its Underlying Profitability?
Aug 18Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
3/31/2027 | 25,826 | 2,622 | 7,616 | 2,965 | 4 |
3/31/2026 | 24,453 | 2,302 | 164 | 912 | 5 |
3/31/2025 | 18,371 | 1,154 | -251 | 5,153 | 5 |
9/30/2024 | 12,512 | -740 | 869 | 1,328 | N/A |
6/30/2024 | 11,411 | -1,091 | N/A | N/A | N/A |
3/31/2024 | 13,715 | -693 | -1,541 | -1,110 | N/A |
12/31/2023 | 16,420 | 736 | N/A | N/A | N/A |
9/30/2023 | 19,343 | 1,107 | -34 | 293 | N/A |
6/30/2023 | 18,595 | 1,272 | N/A | N/A | N/A |
3/31/2023 | 14,884 | 1,041 | 1,792 | 1,977 | N/A |
12/31/2022 | 10,893 | 124 | N/A | N/A | N/A |
9/30/2022 | 9,595 | 447 | 1,541 | 1,732 | N/A |
6/30/2022 | 11,312 | 711 | N/A | N/A | N/A |
3/31/2022 | 11,175 | 794 | 3,429 | 3,549 | N/A |
12/31/2021 | 10,494 | 734 | N/A | N/A | N/A |
9/30/2021 | 9,956 | 905 | 4,123 | 4,179 | N/A |
6/30/2021 | 7,491 | 510 | N/A | N/A | N/A |
3/31/2021 | 6,999 | -55 | 3,180 | 3,238 | N/A |
12/31/2020 | 6,254 | -428 | N/A | N/A | N/A |
9/30/2020 | 5,653 | -784 | 2,724 | 2,818 | N/A |
6/30/2020 | 6,846 | -705 | N/A | N/A | N/A |
3/31/2020 | 11,375 | 724 | 3,245 | 3,349 | N/A |
12/31/2019 | 11,077 | 1,277 | N/A | N/A | N/A |
9/30/2019 | 10,498 | 1,292 | 1,029 | 1,080 | N/A |
6/30/2019 | 10,644 | 1,534 | N/A | N/A | N/A |
3/31/2019 | 8,704 | 754 | 639 | 674 | N/A |
12/31/2018 | 11,539 | 759 | N/A | N/A | N/A |
9/30/2018 | 13,706 | 1,168 | N/A | N/A | N/A |
6/30/2018 | 15,471 | 1,362 | N/A | N/A | N/A |
3/31/2018 | 14,057 | 1,215 | N/A | 2,298 | N/A |
12/31/2017 | 12,565 | 1,124 | N/A | N/A | N/A |
9/30/2017 | 11,953 | 1,024 | N/A | N/A | N/A |
6/30/2017 | 10,324 | 921 | N/A | N/A | N/A |
3/31/2017 | 9,638 | 872 | N/A | 1,426 | N/A |
12/31/2016 | 7,690 | 745 | N/A | N/A | N/A |
9/30/2016 | 7,211 | 702 | N/A | N/A | N/A |
6/30/2016 | 6,761 | 635 | N/A | N/A | N/A |
3/31/2016 | 7,538 | 589 | N/A | 364 | N/A |
12/31/2015 | 6,580 | 546 | N/A | N/A | N/A |
9/30/2015 | 7,134 | 611 | N/A | N/A | N/A |
6/30/2015 | 7,109 | 606 | N/A | N/A | N/A |
3/31/2015 | 6,966 | 653 | N/A | 344 | N/A |
12/31/2014 | 7,246 | 647 | N/A | N/A | N/A |
9/30/2014 | 6,912 | 653 | N/A | N/A | N/A |
6/30/2014 | 6,975 | 849 | N/A | N/A | N/A |
3/31/2014 | 7,642 | 920 | N/A | -1,170 | N/A |
12/31/2013 | 8,045 | 1,241 | N/A | N/A | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: KOLTEPATIL devrait devenir rentable au cours des 3 prochaines années, ce qui est considéré comme une croissance plus rapide que le taux d'épargne ( 6.7% ).
Bénéfices vs marché: KOLTEPATIL devrait devenir rentable au cours des 3 prochaines années, ce qui est considéré comme une croissance supérieure à la moyenne du marché.
Croissance élevée des bénéfices: KOLTEPATIL devrait devenir rentable dans les 3 prochaines années.
Chiffre d'affaires vs marché: Le chiffre d'affaires de KOLTEPATIL ( 26.3% par an) devrait croître plus rapidement que le marché Indian ( 10.5% par an).
Croissance élevée des revenus: Le chiffre d'affaires de KOLTEPATIL ( 26.3% par an) devrait croître plus rapidement que 20% par an.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Le retour sur capitaux propres de KOLTEPATIL devrait être élevé dans 3 ans ( 21.1 %)